We would like to thank each of our sponsors for their generous support - as without them this event would not be possible.

For more information on the sponsor opportunities available, contact Luci Sargood on +44 (0) 207 2406999 or email luci.sargood@pharmatimes.com


CHASE is the UK’s largest independent Contract Sales Organisation (CSO) and recruiter, providing bespoke flexible and permanent staffing solutions to the Pharmaceutical and Healthcare industries. We work with clients across Sales, Marketing, Market Access, Training, Nursing and Clinical.  We are passionate and proactive in what we do and place huge importance on respect and integrity. As a result, we consistently over deliver for our clients and candidates and are renowned for our market leading service levels.


At Star, we’re focused on providing our clients with the very best, bespoke commercial solutions that help them make a real impact, while placing candidates into happy, fulfilling careers with companies they love.

See impact right from the start: contact Operations Director, Mark Ward, on 07872 105 540 or email mark.ward@starmedical.co.uk to discuss innovative outsourcing and resourcing solutions.

If you’re looking for a new role, or are wondering what’s out there, email your CV to candidates@starmedical.co.uk. Alternatively, call 01225 336 335 for our South office, or 0161 914 7660 for our North office to speak to a member of our dedicated team.


ICON plc is a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 90 locations in 37 countries and has approximately 14,000 employees. Further information is available at www.iconplc.com.


Kyowa Kirin International (KKI) is leaping forward to establish itself as a Japan-based global specialty pharmaceutical company. We strive to contribute to the health and well-being of people around the world, and have the goal of answering the unmet medical needs of patients, their families and healthcare professionals.

Our specialty pharmaceutical business was established as ProStrakan in Galashiels in the Scottish Borders, expanding through partnerships and acquisitions before becoming part of Kyowa Hakko Kirin in 2011. The company was rebranded as Kyowa Kirin International in 2016 and has recently opened an office in Marlow, Buckinghamshire.

The company’s focus is in oncology and rare diseases and it is entering into a phase of unprecedented rapid expansion, as it introduces a series of novel treatments which address unmet therapeutic needs. As well as transforming the lives of the patients concerned, this growth will create many exciting new roles across the UK and overseas.

Underlying our business philosophy is a firm commitment to ethical behaviour with key values based on integrity, innovation and teamwork. The interests of the patients our products treat will always be at the centre of what we do.

Kyowa Kirin – Commitment to Life


We have a reputation as one of the UK’s leading suppliers of IT clinical support services, with a strong record in helping clients to reduce costs, increase efficiency and improve outcomes for patients. We have also become a lynchpin in developing mutually beneficial relationships between the pharmaceutical industry and the NHS. We help pharmaceutical clients to improve market access for medicines and products, and facilitate partnerships with the NHS that help patients.

Whether we are working with public sector or private sector clients, we are able to deliver a service that is tailored to meet specific objectives. The vast experience and knowledge we have gained from working with the NHS ensures we deliver outcomes that benefit patients and improve future care provision.

We help pharmaceutical and medical device companies to improve care by facilitating partnerships with the NHS. As part of a Medical Education Goods and Service (MEGS) proposal or Joint working agreement, we can identify patients who may benefit from a review to optimise care.

Also, as part of our promotional services we can identify patients who may fall within the licence indication of a specific brand. In addition, our in-depth knowledge of working with the NHS helps our pharmaceutical clients safely navigate NHS rules and regulations.

Visit us at www.oberoi-consulting.com


A uniquely placed strategy consultancy dedicated to healthcare, Redbow works hand in hand with its clients across many areas of organizational strategy worldwide.  Assignments span strategy development, long range and brand planning to developing marketing academies and helping to build cohesive high performing teams.  

Redbow specialises in the use of gaming methodologies and simulation for strategy development and organisational engagement as well as developing and embedding bespoke strategic planning processes for many clients.

Jonathan Dancer, Managing Director is a firm believer in the power of teams, and whilst most projects focus on the concrete end of strategy and implementation, many revolve additionally around the creation and maintenance of healthy teams that can take their organisations forward.


Key dates

Entry Opens
Entry Closes
Finals day – Singles
Finals day – Communications Team
Finals day – Cross – Functional Team
Gala Dinner & Awards Ceremony
Sales Awards linkcommunication team of the year link